- Home
- Publications
- Publication Search
- Publication Details
Title
The role of cancer-derived microRNAs in cancer immune escape
Authors
Keywords
-
Journal
Journal of Hematology & Oncology
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-29
DOI
10.1186/s13045-020-00848-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer
- (2020) Gaofeng Liang et al. JOURNAL OF NANOBIOTECHNOLOGY
- MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
- (2019) Lanlan Gao et al. EBioMedicine
- MiR-9 promotes tumorigenesis and angiogenesis and is activated by MYC and OCT4 in human glioma
- (2019) Xu Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Nano-Strategies to Target Breast Cancer-Associated Fibroblasts: Rearranging the Tumor Microenvironment to Achieve Antitumor Efficacy
- (2019) Marta Truffi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint
- (2019) Duolu Li et al. EXPERIMENTAL CELL RESEARCH
- miR-20a regulates sensitivity of colorectal cancer cells to NK cells by targeting MICA
- (2019) Siwen Tang et al. BIOSCIENCE REPORTS
- Combination regimens with PD-1/PD-L1 immune checkpoint inhibitors for gastrointestinal malignancies
- (2019) Dongxu Wang et al. Journal of Hematology & Oncology
- MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells
- (2019) Zhong Zheng et al. Molecular Cancer
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Exosomal miRNA-107 induces myeloid-derived suppressor cell expansion in gastric cancer
- (2019) WeiHong Ren et al. Cancer Management and Research
- MiR‐181a regulates CD4 + T cell activation and differentiation by targeting IL‐2 in the pathogenesis of myasthenia gravis
- (2019) Xiaofang Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
- (2019) Hany A. Omar et al. FEBS Journal
- Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death-ligand 1 by sponging microRNA-195-5p
- (2019) Wen-Yang Zhou et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Noncoding RNAs in cancer therapy resistance and targeted drug development
- (2019) Wen-Tao Wang et al. Journal of Hematology & Oncology
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- APRIL Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation via Expression of IL-10 and PD-L1
- (2019) Cynthia M. Fehres et al. Frontiers in Immunology
- MicroRNA-155 Controls T Helper Cell Activation During Viral Infection
- (2019) Eliana Goncalves-Alves et al. Frontiers in Immunology
- Limitations and Off-Target Effects of Tryptophan-Related IDO Inhibitors in Cancer Treatment
- (2019) Juliane Günther et al. Frontiers in Immunology
- Treg-mediated acquired resistance to immune checkpoint inhibitors
- (2019) Reem Saleh et al. CANCER LETTERS
- Blockade of lncRNA-ASLNCS5088–enriched exosome generation in M2 macrophages by GW4869 dampens the effect of M2 macrophages on orchestrating fibroblast activation
- (2019) Jialin Chen et al. FASEB JOURNAL
- Identification of a miR-146b-FasL axis in the development of neutropenia in T large granular lymphocyte leukemia
- (2019) Barbara Mariotti et al. HAEMATOLOGICA
- Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells
- (2019) T. Alissafi et al. JOURNAL OF AUTOIMMUNITY
- Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
- (2019) Xinyu Tian et al. Journal of Hematology & Oncology
- Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis
- (2019) Zheng-Lin Ou et al. RNA Biology
- Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment
- (2019) Monica Marzagalli et al. SEMINARS IN CANCER BIOLOGY
- MicroRNAs that predict the effectiveness of anti-PD-1 therapies in patients with advanced melanoma
- (2019) Satoshi Nakahara et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells
- (2019) Peng-Fei Zhang et al. Molecular Cancer
- Overexpressed miR-195 attenuated immune escape of diffuse large B-cell lymphoma by targeting PD-L1
- (2018) Bai He et al. BIOMEDICINE & PHARMACOTHERAPY
- Targeting myeloid-derived suppressor cells for cancer immunotherapy
- (2018) Yijun Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MiR-140 Expression Regulates Cell Proliferation and Targets PD-L1 in NSCLC
- (2018) Wei-Bin Xie et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- MiR-195/-16 Family Enhances Radiotherapy via T Cell Activation in the Tumor Microenvironment by Blocking the PD-L1 Immune Checkpoint
- (2018) Zhen Tao et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- microRNA 125a Regulates MHC-I Expression on Esophageal Adenocarcinoma Cells, Associated With Suppression of Anti-tumor Immune Response and Poor Outcomes of Patients
- (2018) Luigi Mari et al. GASTROENTEROLOGY
- The miR-3127-5p/p-STAT3 axis up-regulates PD-L1 inducing chemoresistance in non-small-cell lung cancer
- (2018) Dongfang Tang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Cancer immunotherapy beyond immune checkpoint inhibitors
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways
- (2018) Su-Jie Ni et al. Journal of Hematology & Oncology
- Immunoregulatory functions and the therapeutic implications of GARP-TGF-β in inflammation and cancer
- (2018) Alessandra Metelli et al. Journal of Hematology & Oncology
- Next generation of immune checkpoint therapy in cancer: new developments and challenges
- (2018) Julian A. Marin-Acevedo et al. Journal of Hematology & Oncology
- miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
- (2018) Qian Huang et al. Journal of Hematology & Oncology
- Epstein−Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas
- (2018) Eleni Anastasiadou et al. LEUKEMIA
- Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
- (2018) Alexander M.M. Eggermont et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer
- (2018) Peixin Dong et al. ONCOGENE
- Immunosuppressive effects of hypoxia-induced glioma exosomes through myeloid-derived suppressor cells via the miR-10a/Rora and miR-21/Pten Pathways
- (2018) Xiaofan Guo et al. ONCOGENE
- Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
- (2018) Yan Lan et al. Science Translational Medicine
- Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
- (2018) Jae Eun Cheong et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion
- (2018) Cheng Sun et al. Nature Communications
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246
- (2018) Tomer Cooks et al. Nature Communications
- Snail-overexpressing Cancer Cells Promote M2-Like Polarization of Tumor-Associated Macrophages by Delivering MiR-21-Abundant Exosomes
- (2018) Chia-Hsin Hsieh et al. NEOPLASIA
- The possibility of cancer immune editing in gliomas. A critical review
- (2018) Víctor A. Arrieta et al. OncoImmunology
- Exosomes derived from hypoxic epithelial ovarian cancer cells deliver microRNAs to macrophages and elicit a tumor-promoted phenotype
- (2018) Xin Chen et al. CANCER LETTERS
- Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts
- (2018) Jingya Wang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4+ T cells through their microRNA cargo
- (2018) Ji Zhou et al. EXPERIMENTAL CELL RESEARCH
- MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma
- (2018) Fajun Qu et al. JOURNAL OF DRUG TARGETING
- miR-143 Regulates Memory T Cell Differentiation by Reprogramming T Cell Metabolism
- (2018) Tengfei Zhang et al. JOURNAL OF IMMUNOLOGY
- Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors
- (2018) Ming Yi et al. Molecular Cancer
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy
- (2018) Dominik Schmiedel et al. Frontiers in Immunology
- miR-146a Controls Immune Response in the Melanoma Microenvironment
- (2018) Justin Mastroianni et al. CANCER RESEARCH
- Glioma exosomes mediate the expansion and function of myeloid‐derived suppressor cells through microRNA‐29a/ Hbp1 and microRNA‐92a/ Prkar1a pathways
- (2018) Xiaofan Guo et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor-derived microRNAs induce myeloid suppressor cells and predict immunotherapy resistance in melanoma
- (2018) Veronica Huber et al. JOURNAL OF CLINICAL INVESTIGATION
- Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts
- (2018) Yuan Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- Effect of exosomal miRNA on cancer biology and clinical applications
- (2018) Zhenqiang Sun et al. Molecular Cancer
- Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
- (2018) Ling Li et al. ONCOGENE
- MiR-218 produces anti-tumor effects on cervical cancer cells in vitro
- (2018) Li Zhu et al. World Journal of Surgical Oncology
- The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy
- (2017) Theresa L Whiteside Future Oncology
- The emerging role of exosome and microvesicle- (EMV-) based cancer therapeutics and immunotherapy
- (2017) Colin Moore et al. INTERNATIONAL JOURNAL OF CANCER
- miR-768-3p is involved in the proliferation, invasion and migration of non-small cell lung carcinomas
- (2017) Zuozhou Xie et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Human regulatory B cells control the T FH cell response
- (2017) Achouak Achour et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7
- (2017) Lichun Han et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Tumor-associated macrophages: from basic research to clinical application
- (2017) Li Yang et al. Journal of Hematology & Oncology
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma
- (2017) Steven C. Kao et al. Journal of Thoracic Oncology
- MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs
- (2017) A R Pyzer et al. LEUKEMIA
- MicroRNA expression patterns and signalling pathways in the development and progression of childhood solid tumours
- (2017) Anna L. Leichter et al. Molecular Cancer
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Exosomes derived from hypoxic epithelial ovarian cancer deliver microRNA-940 to induce macrophage M2 polarization
- (2017) Xin Chen et al. ONCOLOGY REPORTS
- Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art
- (2017) Francesca Fanini et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- HLA-G: At the Interface of Maternal–Fetal Tolerance
- (2017) Leonardo M.R. Ferreira et al. TRENDS IN IMMUNOLOGY
- Exosomes, DAMPs and miRNA: Features of Stress Physiology and Immune Homeostasis
- (2017) Monika Fleshner et al. TRENDS IN IMMUNOLOGY
- MicroRNA-519a-3p mediates apoptosis resistance in breast cancer cells and their escape from recognition by natural killer cells
- (2017) Christian Breunig et al. Cell Death & Disease
- Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer
- (2017) Jiaying Shen et al. Cell Death & Disease
- The miR-25-93-106b cluster regulates tumor metastasis and immune evasion via modulation of CXCL12 and PD-L1
- (2017) Michele Cioffi et al. Oncotarget
- PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
- (2017) Valentina Audrito et al. Oncotarget
- Immune Modulatory microRNAs Involved in Tumor Attack and Tumor Immune Escape
- (2017) Stefan B. Eichmüller et al. JNCI-Journal of the National Cancer Institute
- Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
- (2016) J. M. Kim et al. ANNALS OF ONCOLOGY
- Inhibition of bromodomain and extra-terminal (BET) proteins increases NKG2D ligand MICA expression and sensitivity to NK cell-mediated cytotoxicity in multiple myeloma cells: role of cMYC-IRF4-miR-125b interplay
- (2016) Maria Pia Abruzzese et al. Journal of Hematology & Oncology
- CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D
- (2016) H Bruns et al. LEUKEMIA
- Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer
- (2016) T Colangelo et al. Cell Death & Disease
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia
- (2015) Xi Wang et al. CELLULAR SIGNALLING
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing
- (2015) Yao-Yin Chang et al. Molecular Cancer
- The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer
- (2015) Yu Fujita et al. MOLECULAR THERAPY
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- PD-L1hi B cells are critical regulators of humoral immunity
- (2015) Adnan R. Khan et al. Nature Communications
- PDL1 Regulation by p53 via miR-34
- (2015) Maria Angelica Cortez et al. JNCI-Journal of the National Cancer Institute
- Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma
- (2015) Shu-biao Ye et al. Oncotarget
- GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer
- (2014) Sifeng Tao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma
- (2014) H Yang et al. BRITISH JOURNAL OF CANCER
- Ovarian tumor-associated microRNA-20a decreases natural killer cell cytotoxicity by downregulating MICA/B expression
- (2014) Jingyan Xie et al. Cellular & Molecular Immunology
- Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
- (2014) Nicole Joller et al. IMMUNITY
- Identification of14-3-3β Gene as a Novel miR-152 Target Using a Proteome-based Approach
- (2014) Simon Jasinski-Bergner et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7
- (2014) Ming-fu Wu et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Cutting Edge: Down-Regulation of MHC Class I-Related Chain A on Tumor Cells by IFN- -Induced MicroRNA
- (2014) D. Yadav et al. JOURNAL OF IMMUNOLOGY
- MiR-451 Suppresses Cell Proliferation and Metastasis in A549 Lung Cancer Cells
- (2014) Pin Yin et al. MOLECULAR BIOTECHNOLOGY
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- miR-9 modulates the expression of interferon-regulated genes and MHC class I molecules in human nasopharyngeal carcinoma cells
- (2013) Fei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization
- (2013) Ji-Young Jang et al. BMC CANCER
- Downregulation of miR-302c and miR-520c by 1,25(OH)2D3 treatment enhances the susceptibility of tumour cells to natural killer cell-mediated cytotoxicity
- (2013) D Min et al. BRITISH JOURNAL OF CANCER
- Hepatitis B surface antigen inhibits MICA and MICB expression via induction of cellular miRNAs in hepatocellular carcinoma cells
- (2013) Jianmin Wu et al. CARCINOGENESIS
- miR-21 Down-Regulation Suppresses Cell Growth, Invasion and Induces Cell Apoptosis by Targeting FASL, TIMP3, and RECK Genes in Esophageal Carcinoma
- (2013) Na Wang et al. DIGESTIVE DISEASES AND SCIENCES
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Regulation of the expression of the liver cancer susceptibility gene MICA by microRNAs
- (2013) Takahiro Kishikawa et al. Scientific Reports
- The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL
- (2012) Peng Wang et al. Molecular Oncology
- MiRNA-Mediated Control of HLA-G Expression and Function
- (2012) Irit Manaster et al. PLoS One
- Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression
- (2012) Xiaohong Wang et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Human leukocyte antigen-G in cancer: Are they clinically relevant?
- (2011) Wei-Hua Yan CANCER LETTERS
- The Unfolded Protein Response (UPR)-activated Transcription Factor X-box-binding Protein 1 (XBP1) Induces MicroRNA-346 Expression That Targets the Human Antigen Peptide Transporter 1 (TAP1) mRNA and Governs Immune Regulatory Genes
- (2011) Rafal Bartoszewski et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses
- (2011) Li Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells
- (2010) Xiao-ming Zhu et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Foxo3a Regulates Apoptosis by Negatively Targeting miR-21
- (2010) Kun Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D
- (2008) Noam Stern-Ginossar et al. NATURE IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now